Uses of VORILASE
A triazole antifungal. Voriconazole is the usual first line agent for invasive aspergillosis and is also active against Candida species including some that resist fluconazole.
Its pharmacokinetics are non linear and vary widely between patients, partly on genetic grounds, so therapeutic drug monitoring is common practice in serious infection rather than an exception.
- Invasive aspergillosis
- Serious Candida infection, including in fluconazole resistant strains
- Other invasive mould infection, as directed
- Empirical antifungal therapy in persistent febrile neutropenia
Indication categories, not an exhaustive list, and not a recommendation for any individual patient.
Quality-driven manufacturing behind VORILASE
Why Monark Criticare versus a typical supplier?
Every row is a term stated elsewhere on this site and held to in writing. Nothing here is a claim about a certificate we have not seen.
Start your critical care business with VORILASE — take the district before it is allocated
Send the districts you cover and the segments you already sell into. You get the rate list, the pack sizes and a straight answer on availability, usually inside one working day.
Get franchise quoteGet franchise quote for VORILASE
Interested in Voriconazole 200mg Injection for your pharma franchise business? Fill the form and we come back with the rate list, the pack sizes and district availability.
- ✓Exclusive district rights, recorded in the agreement
- ✓Net rates, pack sizes and MRP issued before you commit
- ✓No minimum on the first two order cycles
- ✓Batch documentation and certificate of analysis with every consignment
Send enquiry
Fill in your details and we will contact you shortly.
